155 related articles for article (PubMed ID: 11801651)
1. Functional avidity of tumor antigen-specific CTL recognition directly correlates with the stability of MHC/peptide multimer binding to TCR.
Dutoit V; Rubio-Godoy V; Doucey MA; Batard P; Liénard D; Rimoldi D; Speiser D; Guillaume P; Cerottini JC; Romero P; Valmori D
J Immunol; 2002 Feb; 168(3):1167-71. PubMed ID: 11801651
[TBL] [Abstract][Full Text] [Related]
2. Isolation of high avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers.
Yee C; Savage PA; Lee PP; Davis MM; Greenberg PD
J Immunol; 1999 Feb; 162(4):2227-34. PubMed ID: 9973498
[TBL] [Abstract][Full Text] [Related]
3. Alpha 3 domain mutants of peptide/MHC class I multimers allow the selective isolation of high avidity tumor-reactive CD8 T cells.
Pittet MJ; Rubio-Godoy V; Bioley G; Guillaume P; Batard P; Speiser D; Luescher I; Cerottini JC; Romero P; Zippelius A
J Immunol; 2003 Aug; 171(4):1844-9. PubMed ID: 12902485
[TBL] [Abstract][Full Text] [Related]
4. Efficient simultaneous presentation of NY-ESO-1/LAGE-1 primary and nonprimary open reading frame-derived CTL epitopes in melanoma.
Rimoldi D; Rubio-Godoy V; Dutoit V; Lienard D; Salvi S; Guillaume P; Speiser D; Stockert E; Spagnoli G; Servis C; Cerottini JC; Lejeune F; Romero P; Valmori D
J Immunol; 2000 Dec; 165(12):7253-61. PubMed ID: 11120859
[TBL] [Abstract][Full Text] [Related]
5. Positional scanning-synthetic peptide library-based analysis of self- and pathogen-derived peptide cross-reactivity with tumor-reactive Melan-A-specific CTL.
Rubio-Godoy V; Dutoit V; Zhao Y; Simon R; Guillaume P; Houghten R; Romero P; Cerottini JC; Pinilla C; Valmori D
J Immunol; 2002 Nov; 169(10):5696-707. PubMed ID: 12421949
[TBL] [Abstract][Full Text] [Related]
6. Identification of new epitopes from four different tumor-associated antigens: recognition of naturally processed epitopes correlates with HLA-A*0201-binding affinity.
Keogh E; Fikes J; Southwood S; Celis E; Chesnut R; Sette A
J Immunol; 2001 Jul; 167(2):787-96. PubMed ID: 11441084
[TBL] [Abstract][Full Text] [Related]
7. Decreased binding of peptides-MHC class I (pMHC) multimeric complexes to CD8 affects their binding avidity for the TCR but does not significantly impact on pMHC/TCR dissociation rate.
Dutoit V; Guillaume P; Ayyoub M; Hesdorffer CS; Luescher IF; Valmori D
J Immunol; 2003 May; 170(10):5110-7. PubMed ID: 12734357
[TBL] [Abstract][Full Text] [Related]
8. Antimelanoma activity of CTL generated from peripheral blood mononuclear cells after stimulation with autologous dendritic cells pulsed with melanoma gp100 peptide G209-2M is correlated to TCR avidity.
Yang S; Linette GP; Longerich S; Haluska FG
J Immunol; 2002 Jul; 169(1):531-9. PubMed ID: 12077285
[TBL] [Abstract][Full Text] [Related]
9. High avidity antigen-specific CTL identified by CD8-independent tetramer staining.
Choi EM; Chen JL; Wooldridge L; Salio M; Lissina A; Lissin N; Hermans IF; Silk JD; Mirza F; Palmowski MJ; Dunbar PR; Jakobsen BK; Sewell AK; Cerundolo V
J Immunol; 2003 Nov; 171(10):5116-23. PubMed ID: 14607910
[TBL] [Abstract][Full Text] [Related]
10. Tax and M1 peptide/HLA-A2-specific Fabs and T cell receptors recognize nonidentical structural features on peptide/HLA-A2 complexes.
Biddison WE; Turner RV; Gagnon SJ; Lev A; Cohen CJ; Reiter Y
J Immunol; 2003 Sep; 171(6):3064-74. PubMed ID: 12960332
[TBL] [Abstract][Full Text] [Related]
11. Direct phenotypic analysis of human MHC class I antigen presentation: visualization, quantitation, and in situ detection of human viral epitopes using peptide-specific, MHC-restricted human recombinant antibodies.
Cohen CJ; Sarig O; Yamano Y; Tomaru U; Jacobson S; Reiter Y
J Immunol; 2003 Apr; 170(8):4349-61. PubMed ID: 12682272
[TBL] [Abstract][Full Text] [Related]
12. MHC recognition by hapten-specific HLA-A2-restricted CD8+ CTL.
Gagnon SJ; Wang Z; Turner R; Damirjian M; Biddison WE
J Immunol; 2003 Sep; 171(5):2233-41. PubMed ID: 12928367
[TBL] [Abstract][Full Text] [Related]
13. Dissecting TCR-MHC/peptide complex interactions with A2/peptide multimers incorporating tumor antigen peptide variants: crucial role of interaction kinetics on functional outcomes.
Dutoit V; Guillaume P; Cerottini JC; Romero P; Valmori D
Eur J Immunol; 2002 Nov; 32(11):3285-93. PubMed ID: 12555674
[TBL] [Abstract][Full Text] [Related]
14. Prevalent role of TCR alpha-chain in the selection of the preimmune repertoire specific for a human tumor-associated self-antigen.
Dietrich PY; Le Gal FA; Dutoit V; Pittet MJ; Trautman L; Zippelius A; Cognet I; Widmer V; Walker PR; Michielin O; Guillaume P; Connerotte T; Jotereau F; Coulie PG; Romero P; Cerottini JC; Bonneville M; Valmori D
J Immunol; 2003 May; 170(10):5103-9. PubMed ID: 12734356
[TBL] [Abstract][Full Text] [Related]
15. Definition of TCR epitopes for CTL-mediated attack of cutaneous T cell lymphoma.
Winter D; Fiebiger E; Meraner P; Auer H; Brna C; Strohal R; Trautinger F; Knobler R; Fischer GF; Stingl G; Maurer D
J Immunol; 2003 Sep; 171(5):2714-24. PubMed ID: 12928425
[TBL] [Abstract][Full Text] [Related]
16. Antagonism of antiviral and allogeneic activity of a human public CTL clonotype by a single altered peptide ligand: implications for allograft rejection.
Ely LK; Green KJ; Beddoe T; Clements CS; Miles JJ; Bottomley SP; Zernich D; Kjer-Nielsen L; Purcell AW; McCluskey J; Rossjohn J; Burrows SR
J Immunol; 2005 May; 174(9):5593-601. PubMed ID: 15843558
[TBL] [Abstract][Full Text] [Related]
17. Critical role for CD8 in binding of MHC tetramers to TCR: CD8 antibodies block specific binding of human tumor-specific MHC-peptide tetramers to TCR.
Denkberg G; Cohen CJ; Reiter Y
J Immunol; 2001 Jul; 167(1):270-6. PubMed ID: 11418659
[TBL] [Abstract][Full Text] [Related]
18. Vaccination with a Melan-A peptide selects an oligoclonal T cell population with increased functional avidity and tumor reactivity.
Valmori D; Dutoit V; Schnuriger V; Quiquerez AL; Pittet MJ; Guillaume P; Rubio-Godoy V; Walker PR; Rimoldi D; Liénard D; Cerottini JC; Romero P; Dietrich PY
J Immunol; 2002 Apr; 168(8):4231-40. PubMed ID: 11937585
[TBL] [Abstract][Full Text] [Related]
19. Recruitment of CTL activity by tumor-specific antibody-mediated targeting of single-chain class I MHC-peptide complexes.
Lev A; Novak H; Segal D; Reiter Y
J Immunol; 2002 Sep; 169(6):2988-96. PubMed ID: 12218113
[TBL] [Abstract][Full Text] [Related]
20. Identification of NY-ESO-1 peptide analogues capable of improved stimulation of tumor-reactive CTL.
Chen JL; Dunbar PR; Gileadi U; Jäger E; Gnjatic S; Nagata Y; Stockert E; Panicali DL; Chen YT; Knuth A; Old LJ; Cerundolo V
J Immunol; 2000 Jul; 165(2):948-55. PubMed ID: 10878370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
